Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-6901
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease ; volume:22 ; number:2 ; day:5 ; month:4 ; year:2022 ; pages:119-129 ; date:6.2022
Drugs in R & D ; 22, Heft 2 (5.4.2022), 119-129, 6.2022

Creator
Gan, Liangying
Xie, Panpan
Tan, Yan
Wei, Gang
Yuan, Xiaojuan
Lu, Zhifei
Pratt, Raymond
Zhou, Yongchun
Hui, Ai-Min
Li, Kexin
Fang, Yi
Zuo, Li
Contributor
SpringerLink (Online service)

DOI
10.1007/s40268-022-00384-5
URN
urn:nbn:de:101:1-2022080319082758300298
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Gan, Liangying
  • Xie, Panpan
  • Tan, Yan
  • Wei, Gang
  • Yuan, Xiaojuan
  • Lu, Zhifei
  • Pratt, Raymond
  • Zhou, Yongchun
  • Hui, Ai-Min
  • Li, Kexin
  • Fang, Yi
  • Zuo, Li
  • SpringerLink (Online service)

Other Objects (12)

Ferric pyrophosphate citrate: interactions with transferrin

Ferric pyrophosphate citrate: interactions with transferrin

Physicochemical characterization of ferric pyrophosphate citrate

Physicochemical characterization of ferric pyrophosphate citrate

Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis

Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis

Individualized anemia management enhanced by ferric pyrophosphate citrate protocol

Individualized anemia management enhanced by ferric pyrophosphate citrate protocol

Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis

Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis

Antiviral effects of ferric ammonium citrate

Antiviral effects of ferric ammonium citrate

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma

Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma

A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial

A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial

Nitrate Reductase from Chlorella Vulgaris. Reaction with Mangani-Pyrophosphate and with Ferric-o-Phenanthroline

Akten

Nitrate Reductase from Chlorella Vulgaris. Reaction with Mangani-Pyrophosphate and with Ferric-o-Phenanthroline

Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia

Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia

Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study

Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study

Related objects